IP Library › Assignment 050922/0544
Patent Assignment
Reel/Frame 050922/0544

Assignment of Assignor's Interest

Recorded: 2019-11-05 Pages: 4
Assignor
HAGER BIOSCIENCES
Executed: 2019-10-03
Assignee
AGENEBIO, INC.
1340 SMITH AVENUE, SUITE 200, BALTIMORE, MARYLAND, 21209
Covered Property (1)
Benzodiazepine Derivatives, Compositions, and Methods for Treating Cognitive Impairment
Application: 16/445,854 →
Publication: US 2020/0048268
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 5, 2019
From: MEKONNEN, BELEW; BUTERA, JOHN A.; HUANG, JIANXING; PATEL, HEMANTBHAI
To: HAGER BIOSCIENCES
Reel/Frame 050922/0531 →
Assignment of Assignor's Interest Nov 5, 2019
From: ALBANY MOLECULAR RESEARCH, INC.
To: AGENEBIO, INC.
Reel/Frame 050922/0616 →
Assignment of Assignor's Interest Nov 5, 2019
From: JIANG, QIN; HERR, ROBERT JASON; FREEMAN, EMILY ELIZABETH; MAYHEW, NICHOLAS JAMES
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 050936/0142 →
Confirmatory License Jan 17, 2024
From: AGENEBIO, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 066340/0302 →